<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>00860004740315</udiDi>
    <basicUdiDi>03629421032001FK</basicUdiDi>
    <tradeName>HybenX® OTD</tradeName>
    <deviceName>HybenX®  OTD</deviceName>
    <manufacturerName>EPIEN Medical, Inc</manufacturerName>
    <manufacturerSrn>US-MF-000008278</manufacturerSrn>
    <authorisedRepresentativeName>QNET B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000002695</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q019007</emdnCode>
    <emdnDescription>BUCCAL TOPICAL TREATMENT PREPARATIONS NOT INCLUDED IN OTHER CLASSES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>103-2001</reference>
    <placedOnMarketCountry>Netherlands</placedOnMarketCountry>
    <lastUpdated>2026-07-15T20:14:23.242Z</lastUpdated>
  </row>
  <row>
    <udiDi>00362942000020</udiDi>
    <basicUdiDi>03629421050003FX</basicUdiDi>
    <tradeName>00362942000020</tradeName>
    <deviceName>Oralmedic</deviceName>
    <manufacturerName>EPIEN Medical, Inc</manufacturerName>
    <manufacturerSrn>US-MF-000008278</manufacturerSrn>
    <authorisedRepresentativeName>QNET B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000002695</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q019007</emdnCode>
    <emdnDescription>BUCCAL TOPICAL TREATMENT PREPARATIONS NOT INCLUDED IN OTHER CLASSES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>105-0005</reference>
    <placedOnMarketCountry>Netherlands</placedOnMarketCountry>
    <lastUpdated>2026-07-15T20:14:06.361Z</lastUpdated>
  </row>
  <row>
    <udiDi>D701DRY2</udiDi>
    <basicUdiDi>++D701DRYRW</basicUdiDi>
    <tradeName>Dry-Rite Drying Agent</tradeName>
    <deviceName>Dry-Rite</deviceName>
    <manufacturerName>Pulpdent Corporation</manufacturerName>
    <manufacturerSrn>US-MF-000004897</manufacturerSrn>
    <authorisedRepresentativeName>Advena Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>MT-AR-000000234</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q019007</emdnCode>
    <emdnDescription>BUCCAL TOPICAL TREATMENT PREPARATIONS NOT INCLUDED IN OTHER CLASSES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>DRY</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-07-15T15:09:40.879Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-10239J</udiDi>
    <basicUdiDi>B-10239J</basicUdiDi>
    <tradeName>Apiprodent gel za desni</tradeName>
    <deviceName>Apiprodent gel za desni</deviceName>
    <manufacturerName>Apipharma farmaceutsko-prehrambena, kozmetička industrija i trgovina d.o.o.</manufacturerName>
    <manufacturerSrn>HR-MF-000030055</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q019007</emdnCode>
    <emdnDescription>BUCCAL TOPICAL TREATMENT PREPARATIONS NOT INCLUDED IN OTHER CLASSES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>1023</reference>
    <placedOnMarketCountry>Croatia</placedOnMarketCountry>
    <lastUpdated>2026-07-10T21:57:08.810Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-10229G</udiDi>
    <basicUdiDi>B-10229G</basicUdiDi>
    <tradeName>Apirodent sprej</tradeName>
    <deviceName>Apiprodent sprej</deviceName>
    <manufacturerName>Apipharma farmaceutsko-prehrambena, kozmetička industrija i trgovina d.o.o.</manufacturerName>
    <manufacturerSrn>HR-MF-000030055</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q019007</emdnCode>
    <emdnDescription>BUCCAL TOPICAL TREATMENT PREPARATIONS NOT INCLUDED IN OTHER CLASSES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>1022</reference>
    <placedOnMarketCountry>Croatia</placedOnMarketCountry>
    <lastUpdated>2026-07-10T21:57:01.614Z</lastUpdated>
  </row>
  <row>
    <udiDi>04037353002050</udiDi>
    <basicUdiDi>B-04037353002050</basicUdiDi>
    <tradeName>04037353002050</tradeName>
    <deviceName>Saliva Natura</deviceName>
    <manufacturerName>Parnell Pharmaceuticals Limited</manufacturerName>
    <manufacturerSrn>IE-MF-000045495</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q019007</emdnCode>
    <emdnDescription>BUCCAL TOPICAL TREATMENT PREPARATIONS NOT INCLUDED IN OTHER CLASSES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>4037353002050</reference>
    <placedOnMarketCountry>Czechia</placedOnMarketCountry>
    <lastUpdated>2026-07-05T20:06:20.169Z</lastUpdated>
  </row>
  <row>
    <udiDi>86846637688460</udiDi>
    <basicUdiDi>86846637688AFT-G1TK</basicUdiDi>
    <tradeName>GLURAX AFT JEL</tradeName>
    <deviceName>GLURAX AFT JEL</deviceName>
    <manufacturerName>YAREN İLAÇ SANAYİ VE TİCARET ANONİM ŞİRKETİ</manufacturerName>
    <manufacturerSrn>TR-MF-000049862</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q019007</emdnCode>
    <emdnDescription>BUCCAL TOPICAL TREATMENT PREPARATIONS NOT INCLUDED IN OTHER CLASSES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>1003</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-03T15:40:45.906Z</lastUpdated>
  </row>
  <row>
    <udiDi>08437022336381</udiDi>
    <basicUdiDi>843702233600907FQ</basicUdiDi>
    <tradeName>Cubetas para fluorización pequeñas verdes Medicaline</tradeName>
    <deviceName>Cubetas de fluorización Medicaline y Starline</deviceName>
    <manufacturerName>Internacional Ventur S.A.</manufacturerName>
    <manufacturerSrn>ES-MF-000000386</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q019007</emdnCode>
    <emdnDescription>BUCCAL TOPICAL TREATMENT PREPARATIONS NOT INCLUDED IN OTHER CLASSES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>ML90722</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-07-03T12:11:35.557Z</lastUpdated>
  </row>
  <row>
    <udiDi>15036631007493</udiDi>
    <basicUdiDi>5036631ALOCTGL800625</basicUdiDi>
    <tradeName>Alovex Dentizione</tradeName>
    <deviceName>Aloclair Teething Gel</deviceName>
    <manufacturerName>Alliance Pharmaceuticals Limited</manufacturerName>
    <manufacturerSrn>GB-MF-000023165</manufacturerSrn>
    <authorisedRepresentativeName>Alliance Pharma (Ireland) Ltd</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000022483</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q019007</emdnCode>
    <emdnDescription>BUCCAL TOPICAL TREATMENT PREPARATIONS NOT INCLUDED IN OTHER CLASSES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>N/A</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-01T22:36:27.477Z</lastUpdated>
  </row>
  <row>
    <udiDi>15036631009503</udiDi>
    <basicUdiDi>5036631ALOCTGL800625</basicUdiDi>
    <tradeName>Alovex Dentizione</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Alliance Pharmaceuticals Limited</manufacturerName>
    <manufacturerSrn>GB-MF-000023165</manufacturerSrn>
    <authorisedRepresentativeName>Alliance Pharma (Ireland) Ltd</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000022483</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q019007</emdnCode>
    <emdnDescription>BUCCAL TOPICAL TREATMENT PREPARATIONS NOT INCLUDED IN OTHER CLASSES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>N/A</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T07:36:11.254Z</lastUpdated>
  </row>
  <row>
    <udiDi>15036631009510</udiDi>
    <basicUdiDi>5036631ALOCTGL800625</basicUdiDi>
    <tradeName>Aloclair Teething Gel</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Alliance Pharmaceuticals Limited</manufacturerName>
    <manufacturerSrn>GB-MF-000023165</manufacturerSrn>
    <authorisedRepresentativeName>Alliance Pharma (Ireland) Ltd</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000022483</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q019007</emdnCode>
    <emdnDescription>BUCCAL TOPICAL TREATMENT PREPARATIONS NOT INCLUDED IN OTHER CLASSES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>N/A</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T07:36:11.239Z</lastUpdated>
  </row>
  <row>
    <udiDi>15036631010134</udiDi>
    <basicUdiDi>5036631ALOCTGL800625</basicUdiDi>
    <tradeName>Anaftin Baby Gel gingival</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Alliance Pharmaceuticals Limited</manufacturerName>
    <manufacturerSrn>GB-MF-000023165</manufacturerSrn>
    <authorisedRepresentativeName>Alliance Pharma (Ireland) Ltd</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000022483</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q019007</emdnCode>
    <emdnDescription>BUCCAL TOPICAL TREATMENT PREPARATIONS NOT INCLUDED IN OTHER CLASSES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>N/A</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T07:36:11.114Z</lastUpdated>
  </row>
  <row>
    <udiDi>15036631010141</udiDi>
    <basicUdiDi>5036631ALOCTGL800625</basicUdiDi>
    <tradeName>Alobaby Primeiros Dentes</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Alliance Pharmaceuticals Limited</manufacturerName>
    <manufacturerSrn>GB-MF-000023165</manufacturerSrn>
    <authorisedRepresentativeName>Alliance Pharma (Ireland) Ltd</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000022483</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q019007</emdnCode>
    <emdnDescription>BUCCAL TOPICAL TREATMENT PREPARATIONS NOT INCLUDED IN OTHER CLASSES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>N/A</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T07:36:11.099Z</lastUpdated>
  </row>
  <row>
    <udiDi>15036631010158</udiDi>
    <basicUdiDi>5036631ALOCTGL800625</basicUdiDi>
    <tradeName>Aloclair Gél na detské ďasná</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Alliance Pharmaceuticals Limited</manufacturerName>
    <manufacturerSrn>GB-MF-000023165</manufacturerSrn>
    <authorisedRepresentativeName>Alliance Pharma (Ireland) Ltd</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000022483</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q019007</emdnCode>
    <emdnDescription>BUCCAL TOPICAL TREATMENT PREPARATIONS NOT INCLUDED IN OTHER CLASSES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>N/A</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T07:36:11.080Z</lastUpdated>
  </row>
  <row>
    <udiDi>15036631010189</udiDi>
    <basicUdiDi>5036631ALOCTGL800625</basicUdiDi>
    <tradeName>Anaftin Baby gelis dygstant dantukams</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Alliance Pharmaceuticals Limited</manufacturerName>
    <manufacturerSrn>GB-MF-000023165</manufacturerSrn>
    <authorisedRepresentativeName>Alliance Pharma (Ireland) Ltd</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000022483</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q019007</emdnCode>
    <emdnDescription>BUCCAL TOPICAL TREATMENT PREPARATIONS NOT INCLUDED IN OTHER CLASSES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>N/A</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T07:36:11.070Z</lastUpdated>
  </row>
  <row>
    <udiDi>15036631010196</udiDi>
    <basicUdiDi>5036631ALOCTGL800625</basicUdiDi>
    <tradeName>Anaftin Baby Żel na ząbkowanie</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Alliance Pharmaceuticals Limited</manufacturerName>
    <manufacturerSrn>GB-MF-000023165</manufacturerSrn>
    <authorisedRepresentativeName>Alliance Pharma (Ireland) Ltd</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000022483</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q019007</emdnCode>
    <emdnDescription>BUCCAL TOPICAL TREATMENT PREPARATIONS NOT INCLUDED IN OTHER CLASSES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>N/A</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T07:36:11.053Z</lastUpdated>
  </row>
  <row>
    <udiDi>15036631010202</udiDi>
    <basicUdiDi>5036631ALOCTGL800625</basicUdiDi>
    <tradeName>Anaftin Baby gel kod nicanja zubi</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Alliance Pharmaceuticals Limited</manufacturerName>
    <manufacturerSrn>GB-MF-000023165</manufacturerSrn>
    <authorisedRepresentativeName>Alliance Pharma (Ireland) Ltd</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000022483</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q019007</emdnCode>
    <emdnDescription>BUCCAL TOPICAL TREATMENT PREPARATIONS NOT INCLUDED IN OTHER CLASSES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>N/A</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T07:36:11.033Z</lastUpdated>
  </row>
  <row>
    <udiDi>15036631010219</udiDi>
    <basicUdiDi>5036631ALOCTGL800625</basicUdiDi>
    <tradeName>Anaftin Baby fogínygél</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Alliance Pharmaceuticals Limited</manufacturerName>
    <manufacturerSrn>GB-MF-000023165</manufacturerSrn>
    <authorisedRepresentativeName>Alliance Pharma (Ireland) Ltd</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000022483</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q019007</emdnCode>
    <emdnDescription>BUCCAL TOPICAL TREATMENT PREPARATIONS NOT INCLUDED IN OTHER CLASSES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>N/A</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T07:36:11.019Z</lastUpdated>
  </row>
  <row>
    <udiDi>15036631010226</udiDi>
    <basicUdiDi>5036631ALOCTGL800625</basicUdiDi>
    <tradeName>Anaftin Baby gels zobu šķilšanās laikā</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Alliance Pharmaceuticals Limited</manufacturerName>
    <manufacturerSrn>GB-MF-000023165</manufacturerSrn>
    <authorisedRepresentativeName>Alliance Pharma (Ireland) Ltd</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000022483</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q019007</emdnCode>
    <emdnDescription>BUCCAL TOPICAL TREATMENT PREPARATIONS NOT INCLUDED IN OTHER CLASSES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>N/A</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T07:36:11.005Z</lastUpdated>
  </row>
  <row>
    <udiDi>15036631010233</udiDi>
    <basicUdiDi>5036631ALOCTGL800625</basicUdiDi>
    <tradeName>Анафтин бебе гел при</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Alliance Pharmaceuticals Limited</manufacturerName>
    <manufacturerSrn>GB-MF-000023165</manufacturerSrn>
    <authorisedRepresentativeName>Alliance Pharma (Ireland) Ltd</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000022483</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q019007</emdnCode>
    <emdnDescription>BUCCAL TOPICAL TREATMENT PREPARATIONS NOT INCLUDED IN OTHER CLASSES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>N/A</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T07:36:10.985Z</lastUpdated>
  </row>
</eudamedExport>